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Review methods:
Research of clinical guidelines (CG), computer decision
support systems (CS), systematic reviews (SR) and original
studies (January 2008 to May 2011). MeSH terms: venous
thrombosis; heparin, low-molecular-weight; anti-
inflammatory agents. American Family Physician’s Strength
of Recommendation Taxonomy (SORT) was used to assess
the level of evidence. Data sources: Pubmed database,
evidence-based medicine websites, General Directorate of
Health, Portuguese Association of General Practitioners,
MGFamiliar.net, Index of Portuguese Medical Magazines.
Objective:
Review the available evidence about the best treatment of superficial thrombophlebitis (ST) of the lower limb (LL), regarding
nonsteroidal anti-inflammatory drugs (NSAIDs) and low-molecular-weight heparin (LMWH).
Results:
Conclusions:
 LMWH and NSAIDs are two first-line treatment options (SOR B).
When associated with risk factors for complications, the use of intermediate/therapeutic doses of LMWH for at least 4
weeks is a first-line treatment option (SOR B).
 More RCT are needed, particularly regardind the choice between LMWH or NSAIDs or its’ simultaneous use, doses and
treatment’s length.
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Authors Recommendations SOR
CG American College of
Chest Physicians1
1st line: Prophylactic/intermediate doses of
LMWH or intermediate doses of UFH* for at least
4 weeks.
Alternative: 4 weeks of VKA** (target INR, 2.0 to
3.0) + UFH and LMWH in the first 5 days .
NSAIDs + anticoagulation should not be used.
The authors suggest the use of oral or topical
NSAIDs in less extensive ST. (without
recommendation)
B
C
B
-
CS Fernandez L, et al.2 Low risk for DVT***: Oral NSAIDs
High risk for DVT: Anticoagulation for 4 weeks
[LMWH, UFH, VKA, equally effective]
B
B
Authors Population Intervention Conclusion Level of
evidence
SR Di Nisio M, et al.3
24 RCT ****
n=2469
ST
LMWH, UFH, VKA, NSAIDs
Topical treatment
Surgery
1st line: 
LMWH or NSAIDs
Authors remark:
Intermediate dose of
LMWH for 4 weeks
2
RCT Uncu H4 n=50
ST of greater
saphenous
vein
25 patients: 
Nadroparin (190 IU/Kg, 
once daily)
25 patients: 
Nadroparin (190 IU/Kg, 
once daily) + Acemetacine
(60 mg, twice daily)  
More effective:
Combined therapy of
LMWH and anti-
inflammatory
2
215 records identified through
database searching
Population: Patients with a diagnosis of ST of LL. 
Intervention: LMWH and/or NSAIDs.
Comparison: Other therapies.
Outcomes: Pain relief; prevention of complications. 
Exclusion criteria:
Repeated articles; deep venous thrombosis isolated;
hospital context; ST not in LL; paediatric; pregnancy;
ST complicated or associated with pathological
conditions that increase the risk; prophylaxis of TS.
4 articles selected
Label:
* Unfractionated Heparin
** Vitamin K Antagonist
*** Deep Vein Thrombosis
**** Randomized Clinical Trial
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